from Yahoo Finance https://ift.tt/2YXxVPV
-
LabCorp expands availability of at-home sample collection kit for COVID-19 testing
from Yahoo Finance https://ift.tt/2T1fHcN
-
U.S. FDA declines to review Bristol Myers, bluebird therapy for multiple myeloma
from Yahoo Finance https://ift.tt/2WUgWeC
The Latest
-
This ASX biotech is pushing for a Nasdaq listing. Could it reignite investor interest?
-
3 ASX 200 shares just upgraded to strong buy — here’s what the brokers are saying
-
2 ASX ETFs up 35% or more in 2026
-
These 4 ASX 200 shares have slumped to fresh 52-week lows: Buy, sell or hold?